These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26826488)

  • 21. Immunotherapy of tumor by targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Sci China C Life Sci; 2004 Dec; 47(6):545-52. PubMed ID: 15620111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
    Tartour E; Pere H; Maillere B; Terme M; Merillon N; Taieb J; Sandoval F; Quintin-Colonna F; Lacerda K; Karadimou A; Badoual C; Tedgui A; Fridman WH; Oudard S
    Cancer Metastasis Rev; 2011 Mar; 30(1):83-95. PubMed ID: 21249423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.
    Missiaen R; Mazzone M; Bergers G
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):107-116. PubMed ID: 29935312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.
    Gaddy TD; Wu Q; Arnheim AD; Finley SD
    PLoS Comput Biol; 2017 Dec; 13(12):e1005874. PubMed ID: 29267273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer.
    Georganaki M; van Hooren L; Dimberg A
    Front Immunol; 2018; 9():3081. PubMed ID: 30627131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
    Bencsikova B; Budinska E; Selingerova I; Pilatova K; Fedorova L; Greplova K; Nenutil R; Valik D; Obermannova R; Sheard MA; Zdrazilova-Dubska L
    BMC Cancer; 2019 Jul; 19(1):687. PubMed ID: 31307428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
    Bachelier R; Confavreux CB; Peyruchaud O; Croset M; Goehrig D; van der Pluijm G; Clézardin P
    Int J Cancer; 2014 Sep; 135(6):1319-29. PubMed ID: 24615579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor angiogenesis and anti-angiogenic therapies.
    Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
    Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
    Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
    Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.
    Hegde PS; Wallin JJ; Mancao C
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):117-124. PubMed ID: 29229461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.
    Itatani Y; Kawada K; Yamamoto T; Sakai Y
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment.
    Hu C; Jiang X
    Biomed Pharmacother; 2017 Apr; 88():134-137. PubMed ID: 28103506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
    Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
    BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-VEGF antibody enhances the antitumor effect of CD40.
    Selvaraj S; Raundhal M; Patidar A; Saha B
    Int J Cancer; 2014 Oct; 135(8):1983-8. PubMed ID: 24604357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Angiogenics: Their Value in Lung Cancer Therapy.
    Janning M; Loges S
    Oncol Res Treat; 2018; 41(4):172-180. PubMed ID: 29631257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression.
    Johnson B; Osada T; Clay T; Lyerly H; Morse M
    Curr Mol Med; 2009 Aug; 9(6):702-7. PubMed ID: 19689297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.